Bromocriptine (Parlodel) . a prolactin inhibiting dopamine receptor agonist
Andersen, A.N.
Ugeskrift for Laeger 139(22): 1311-1313
1977
ISSN/ISBN: 0041-5782 PMID: 577320 Document Number: 116323
Document emailed within 1 workday
Related Documents
Ceccherini-Nelli, A.; Guazzelli, M. 1994: Treatment of refractory OCD with the dopamine agonist bromocriptine Journal of Clinical Psychiatry 55(9): 415-416Malmberg; Mikaels; Mohell, N. 1998: Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding Journal of Pharmacology and Experimental Therapeutics 285(1): 119-126
Onclin, K.; Silva, L.D.; Donnay, I.; Verstegen, J.P. 1993: Luteotrophic action of prolactin in dogs and the effects of a dopamine agonist, cabergoline Journal of Reproduction and Fertility. Supplement 47: 403-409
Maeda, T.; Sawada, K.; Itoh, Y.; Moriwaki, K.; Mori, H. 1991: Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist Laboratory Investigation; a Journal of Technical Methods and Pathology 65(6): 679-687
Buvat, J.; Buvat-Herbaut, M. 1982: Prolactin, bromocriptine and gonadal function in women: recent advances. II. Treatment of female hyperprolactinemia and other indications for the use of bromocriptine Journal de Gynecologie Obstetrique et Biologie de la Reproduction 11(4): 509-521
Arnerić, S.P.; Long, J.P.; Williams, M.; Goodale, D.B.; Mott, J.; Lakoski, J.M.; Gebhart, G.F. 1983: RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist Journal of Pharmacology and Experimental Therapeutics 224(1): 161-170
Hahn, R.A.; Wardell, J.R.; Sarau, H.M.; Ridley, P.T. 1982: Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist Journal of Pharmacology and Experimental Therapeutics 223(2): 305-313
Hahn, R.A.; MacDonald, B.R.; Martin, M.A. 1983: Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist Journal of Pharmacology and Experimental Therapeutics 224(1): 206-214
Margalioth, E.J.; Navot, D.; Rabinowitz, R.; Laufer, N.; Lewin, A.; Schenker, J.G. 1986: The combined use of human menopausal gonadotropin and Parlodel (bromocriptine) for in vitro fertilization International Journal of Fertility 31(4): 278; 282-283
Carratù, M.R.; De Serio, A.; Lagioia, R.; Conte-Camerino, D.; Ferrari, E.; Mitolo-Chieppa, D. 1990: Effects of the partial dopamine receptor agonist, terguride, on the field-stimulated vas deferens in the mouse Bollettino della Societa Italiana di Biologia Sperimentale 66(1): 35-42
Hahn, R.A.; MacDonald, B.R. 1984: Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist Journal of Pharmacology and Experimental Therapeutics 230(3): 558-568
Chen, C.J.; Apparsundaram, S.; Lokhandwala, M.F. 1991: Intrarenally produced angiotensin Ii opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats Journal of Pharmacology and Experimental Therapeutics 256(2): 486-491
Wreggett, K.A.; Seeman, P. 1984: Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide Molecular Pharmacology 25(1): 10-17
Zhu, D.; Wang, L.; Li, Y.; Zhu, Y.; Zhao, P. 2010: Effects of retinoic acid receptor agonist and retinoid X receptor agonist on the expression of IL-4 and IFN-gamma in cord blood mononuclear cells Wei Sheng Yan Jiu 39(4): 433-435
Mayuzumi, T. 2005: Vascular endothelial growth factor (VEGF) production by a dopamine D2 receptor agonist and its action mechanism in glioma cells Hokkaido Journal of Medical Science 80(1): 115-123
Sud, S.C. 1972: Effect of melengestrol acetate on pituitary prolactin and hypothalamic prolactin-inhibiting factor Indian Journal of Experimental Biology 10(1): 13-15
Rosa, A.A.; Djiane, J.; Houdebine, L.M.; Kelly, P.A. 1982: Stimulatory effects of prolactin and anti-prolactin receptor serum on prolactin binding sites in rat liver cells in suspension culture Biochemical and Biophysical Research Communications 106(1): 243-249
Mack, R.B. 1988: Mairzy doats and dozy doats and a kiddle eat almost anything. Bromocriptine (Parlodel) overdose North Carolina Medical Journal 49(1): 17-18
Ziabreva, E.V.; Kapeliovich, M.R.; Gitel', E.P.; Podzolkov, V.I. 1988: Prolactin levels and the hemodynamic effects of parlodel in patients with the initial stages of hypertension Kardiologiia 28(1): 24-27
Mel'nichenko, G.A.; Bol'shakova, T.D.; Gitel', E.P.; Langner, T.K.; Barkova, M.V. 1983: Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases Problemy Endokrinologii 29(1): 19-23